Abstract:Tumor immunotherapy is the fourth therapy after surgery, chemotherapy, and radiotherapy. It has made great breakthroughs in the treatment of some epithelial tumors and hematological tumors. However, its adverse reactions are common or even more serious, and the response rate in some solid tumors is not satisfactory. With the maturity of genomics and metabolomics technologies, the effect of intestinal microbiota in tumor development and treatment has gradually been recognized. The microbiota may affect tumor immunity by regulating the host immune system and tumor microenvironment. Some bacteria help fight tumors by activating immunity, while some bacteria mediate immunosuppression to help cancer cells escape from the immune system. More and more studies have revealed that the effects and complications of tumor immunotherapy are related to the composition of the gut microbiota. The composition of the intestinal microbiota that is sensitive to treatment or prone to adverse reactions has certain characteristics. These characteristics may be used as biomarkers to predict the prognosis of immunotherapy and may also be developed as “immune potentiators” to assist immunotherapy. Some clinical and preclinical studies have proved that microbial intervention, including microbial transplantation, can improve the sensitivity of immunotherapy or reduce adverse reactions to a certain extent. With the development of gene editing technology and nanotechnology, the design and development of engineered bacteria that contribute to immunotherapy has become a new research hotspot. Based on the relationship between the intestinal microbiota and immunotherapy, the correct mining of microbial information and the development of reasonable and feasible microbial intervention methods are expected to optimize tumor immunotherapy to a large extent and bring new breakthroughs in tumor treatment.

The Role of The Tumor Microbiome in Tumor Development and Its Treatment

Microbiota Regulates Pancreatic Cancer Carcinogenesis through Altered Immune Response.

Beyond the Gut: The intratumoral microbiome's influence on tumorigenesis and treatment response.

The role of gut microbiota in tumorigenesis and treatment

Microbiota in tumors: new factor influencing cancer development

Intratumor microbiota in cancer pathogenesis and immunity: from mechanisms of action to therapeutic opportunities

Gut microbiota and its therapeutic implications in tumor microenvironment interactions

Microbiota in cancer: molecular mechanisms and therapeutic interventions

Microbiota in Tumors: from Understanding to Application

The Role of Gut Microbiota in Tumor Immunotherapy

Emulating interactions between microorganisms and tumor microenvironment to develop cancer theranostics

Gut Microbiota-Mediated Modulation of Cancer Progression and Therapy Efficacy

Tumor-related Microbiome in the Breast Microenvironment and Breast Cancer

Microbiome Harbored Within Tumors:A New Chance to Revisit Our Understanding of Cancer Pathogenesis and Treatment

The Emerging Tumor Microbe Microenvironment: from Delineation to Multidisciplinary Approach-Based Interventions

Role of Respiratory System Microbiota in Development of Lung Cancer and Clinical Application

Influence of Microbiota on Tumor Immunotherapy

Research progress of microorganisms in tumor microenvironment

The role of the bacterial microbiome in the treatment of cancer

The critical role of tumor microbiome in cancer immunotherapy

Role of the intratumoral microbiome in tumor progression and therapeutics implications